Acurx Pharmaceuticals, Inc. (ACXP)
1.83
-0.02
(-1.08%)
USD |
NASDAQ |
Feb 20, 10:34
Acurx Pharmaceuticals EPS Diluted (Quarterly) : -1.226 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Adial Pharmaceuticals, Inc. | -2.022 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.993M |
| Total Expenses (Quarterly) | 1.993M |
| Enterprise Value | -1.195M |
| Earnings Yield | -354.5% |
| Normalized Earnings Yield | -354.48 |